Skip to main content
    H

    Humana Inc (HUM)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NYSE

    $461.15
    +11.15 (+2.48%)

    Market Cap: $54.05B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Humana Inc (HUM) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Humana (HUM) trades at 34.8x trailing earnings and 0.4x sales. Its P/E of 34.8x is above its 5-year median of 17.4x. Its forward P/E is 28.3x. The median P/E across 12 similar companies is 17.0x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 23.0% higher over the next year. Its free cash flow yield is 5.7%.

    MultipleValue
    P/E (trailing)34.8x
    Forward P/E28.3x
    Price to sales0.4x
    Price to book2.9x
    EV/EBITDA18.7x
    Price to FCF17.6x
    EV/FCF19.4x
    PEG1.3
    FCF yield5.7%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 76.6% above 19.7x, its P/S is 33.3% below 0.6x and its P/B is 14.7% below 3.4x.

    MultipleCurrent5-year median10-year median
    P/E34.8x17.4x19.7x
    P/S0.4x0.4x0.6x
    P/B2.9x2.6x3.4x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 15.0x in 2025 to 22.5x in 2021. 2025 was the lowest of those years.

    Year endPriceP/EP/SP/B
    2025$256.1315.0x0.2x1.7x
    2024$253.7115.7x0.3x1.9x
    2023$457.8117.6x0.5x3.4x
    2022$512.1920.3x0.7x4.2x
    2021$463.8622.5x0.7x3.7x
    2020$410.2721.9x0.7x3.9x
    2019$366.5220.5x0.8x4.1x
    2018$286.4819.7x0.7x3.9x
    2017$248.0721.2x0.7x3.6x
    2016$204.0321.6x0.6x2.9x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About HUM

    What is HUM's forward P/E ratio?

    Humana has a forward P/E ratio of 28.3x.

    Is HUM stock overvalued?

    GNG's valuation label for HUM is Fairly valued. Its P/E of 34.8x compares with a median of 17.0x across 12 similar companies.

    What is HUM's price to sales ratio?

    Humana has a price to sales ratio of 0.4x.

    What is Humana's average P/E ratio over 5 years?

    Humana's median P/E over the last 5 years is 17.4x, from 60 month-end values through Oct 2026.

    What is HUM's PEG ratio?

    Humana has a PEG ratio of 1.3.